Predicting undetectable MRD in newly-diagnosed multiple myeloma
This webpage was designed for predicting undetectable MRD in newly-diagnosed multiple myeloma patients using tumor burden, cytogenetic abnormalities and tumor immune microenvironment biomarkers from a machine learning algorithm. [NEW: The model is now able to impute missing cytogenetic abnormalities and tumor burden (i.e. PC clonality and circulating tumor cells) based on a nearest-neighbor approach. If you are missing these variables, simply type missing]